There was a negative association between CTNNB1 mutations and MMR deficiency in our cohort, which supports evidence from previous larger study that showed that CTNNB1 mutations were less frequent in MSI positive tumours [47], although the mechanism accounting for this negative correlation has yet to be elucidated. This evidence concerns the gene CTNNB1 and neoplasm.